Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0008272 (
chlorosis
)
2,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ligands of the 3-hydroxy-4-pyridinone (3,4-HPO) class were considered eligible to formulate new Fe fertilizers for Iron Deficiency
Chlorosis
(IDC). Soybean (
Glycine max
L.) plants grown in hydroponic conditions and supplemented with Fe-chelate [Fe(mpp)
3
] were significantly greener, had increased biomass, and were able to translocate more iron from the roots to the shoots than those supplemented with an equal amount of the commercially available chelate [FeEDDHA]. To understand the influence of the structure of 3,4-HPO ligand on the role of the Fe-chelate to improve Fe-uptake, we investigated and report here the effect of Fe-chelates ([Fe(mpp)
3
], [Fe(dmpp)
3
], and [Fe(etpp)
3
]) in addressing IDC.
Chlorosis
development was assessed by measurement of morphological parameters, quantification of chlorophyll and Fe, and other micronutrient contents, as well as measurement of enzymatic activity (FCR) and gene expression (FRO2, IRT1, and
Ferritin
). All [Fe(3,4-HPO)
3
] chelates were able to provide Fe to plants and prevent IDC but with a different efficiency depending on the ligand. We hypothesize that this may be related with the distinct physicochemical characteristics of ligands and complexes, namely, the diverse hydrophilic-lipophilic balance of the three chelates. To test the hypothesis, we performed an EPR biophysical study using liposomes prepared from a soybean (
Glycine3 max
L.) lipid extract and spin probes. The results showed that the most effective chelate [Fe(mpp)
3
] shows a preferential location close to the surface while the others prefer the hydrophobic region inside the bilayer.
...
PMID:A combined physiological and biophysical approach to understand the ligand-dependent efficiency of 3-hydroxy-4-pyridinone Fe-chelates. 3282 74